<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study compared the therapeutical effect of the prolonged administration of albumin, 2 g/kg body weight per day, with that of saline or <z:chebi fb="0" ids="52071">dextran</z:chebi>, 0.8 g/kg body weight per day, on <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, using an occlusion of the middle cerebral artery in the rat </plain></SENT>
<SENT sid="1" pm="."><plain>Brain water, <z:chebi fb="199" ids="26708">sodium</z:chebi>, and <z:chebi fb="120" ids="26216">potassium</z:chebi> contents were measured 72 hours after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The volume of infarction was represented as volume index, which is a total of the infarction area measured in the five brain slices at 168 hours after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The postischemic administration of albumin at the dose tested elucidated an antiedema effect and reduced the infarction size after regional <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>These results strongly support the idea that hemodilution therapy with colloids such as albumin has wide usage as a treatment of patients with ischemic cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>